3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Moderate Hepatic Impairment
1
Meningioma
1
Lymphoma
1
Lung Neoplasms
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chondrosarcoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Endometrioid
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
8
Mycophenolic Acid
6
Whole-Body Irradiation
5
Busulfan
5
fludarabine phosphate
4
fludarabine
4
Tacrolimus
4
Cyclosporine
4
Rituximab
3
Prednisone
3
Methotrexate
3
Inotuzumab Ozogamicin
3
Etoposide
3
Cytarabine
3
venetoclax
2
ruxolitinib
2
pegfilgrastim
2
asciminib
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mercaptopurine
2
Filgrastim
2
Dexamethasone
2
Calcium Dobesilate
2
tocilizumab
1
ricolinostat
1
rasburicase
1
ponatinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
capivasertib
×
30 days
×
Clear all
No trials found.